Release kinetics of cardiac biomarkers in patients undergoing valve replacement surgery for rheumatic heart disease

Results Mean baseline BNP, TnI and CK-MB levels were 304.01 pg/ml, 0.03 ng/ml and 0.99 ng/ml. BNP initially decreased within 6 hours of surgery, and peaked at 24 hours; TnI and CKMB showed an early rise, with declining trends by 24 hrs. Peak BNP levels occurred in 90% patients by 24-48 hrs, while for TnI and CKMB this occurred in only 15-30%. Mean delta (peak-baseline) BNP, TnI, CKMB was 660.1pg/ml, 8.1ng/ml and 32.3ng/ml. At 1 month, levels of all biomarkers were not significantly different from baseline. Patients with higher baseline BNP more commonly had atrial fibrillation (71vs 33%,p=.02), higher right ventricular systolic pressure (69.7vs43.9 mm Hg, p< 0.001), higher Euroscore II(2.42vs1.49,p=0.006), longer inotrope duration (56.1vs26.5hrs,p=0.03), ventilator support time (35.6vs21.7 hrs,p=0.04), longer ICU (4.8vs3.2 days,p=0.02) and hospital stay (6.8vs5.2 days,p=0.03). Inotrope duration>42 hrs, ventilation time>29 hrs and ICU stay>4 days was seen in 42%vs19%, 30%vs9% and 33%vs14% respectively in patients with baseline BNP >/< 200 pg/ml. Only baseline BNP was a significant predictor of inotrope duration (p=0.01) and ventilation time (p=0.02). Only 24 hour post-operative BNP and delta BNP were predictors of inotrope duration>42 hrs, ventilation time>29 hrs and ICU stay>4 days.